Search Browse Earnings

LakeShore Biopharma Co., Ltd.

OTC:LSBCFOTC:LSBWF

Pharmaceutical Preparations·DAXING DISTRICT, BEIJING, F4

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$85.7M

+6.0% YoY

FY 2025

Adj. EBITDA

-$7.9M

-9.2% margin

FY 2025

Net Income

-$13.9M

-16.3% margin

FY 2025

EPS (Diluted)

-$0.73

FY 2025

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$53.9M

FY 2023

Total Debt

$31.5M

FY 2025

Net Cash

$22.4M

FY 2025

Enterprise Value

—

Debt / EBITDA

2.8x

FY 2025

EV / EBITDA

—

Employees

—